{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:48:16Z","timestamp":1793792896544,"version":"4.6.1"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["FRGS\/1\/2023\/ SKK15 \/USM\/02\/3"],"award-info":[{"award-number":["FRGS\/1\/2023\/ SKK15 \/USM\/02\/3"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004595","name":"Universiti Sains Malaysia","doi-asserted-by":"publisher","award":["R501-LR-RND002\\u20130000000331-0000"],"award-info":[{"award-number":["R501-LR-RND002\\u20130000000331-0000"]}],"id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.intimp.2026.116832","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:52:01Z","timestamp":1778881921000},"page":"116832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["cGAS-STING Signalling in the tumour microenvironment: Implications for immune surveillance and therapeutic strategies"],"prefix":"10.1016","volume":"182","author":[{"given":"Teeb Yasir Mahmoud","family":"Al-Adayleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Sarah Fazalul","family":"Rahiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikneswaran","family":"Murugaiyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafeezul","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryar","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmeh Saad","family":"Al-Ramamneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Attiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116832_bb0005","article-title":"\u201cThe cytosolic DNA-sensing cGAS\u2013sting pathway in cancer,\u201d Jan. 01, 2020, American Association for Cancer Research Inc.","author":"Won","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.116832_bb0010","article-title":"\u201cRegulation and function of the cGAS-STING pathway of cytosolic DNA sensing,\u201d Sep. 20, 2016, Nature Publishing Group","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"issue":"7454","key":"10.1016\/j.intimp.2026.116832_bb0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature12306","article-title":"CGAS produces a 2\u2032-5\u2032-linked cyclic dinucleotide second messenger that activates STING","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116832_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.646304","article-title":"STING operation at the ER\/Golgi interface","author":"Taguchi","year":"2021","journal-title":"Front. Immunol."},{"issue":"214","key":"10.1016\/j.intimp.2026.116832_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2002521","article-title":"STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway","volume":"5","author":"Tanaka","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2026.116832_bb0030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI11830","article-title":"NF-\u03baB: a key role in inflammatory diseases","author":"Tak","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.intimp.2026.116832_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110138","article-title":"IFI16 inhibits DNA repair that potentiates type-I interferon-induced antitumor effects in triple negative breast cancer","volume":"37","author":"Ka","year":"2021","journal-title":"Cell Rep."},{"issue":"7747","key":"10.1016\/j.intimp.2026.116832_bb0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","article-title":"Autophagy induction via STING trafficking is a primordial function of the cGAS pathway","volume":"567","author":"Gui","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2026.116832_bb0045","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112387","article-title":"STING directly recruits WIPI2 for autophagosome formation during STING-induced autophagy","volume":"42","author":"Wan","year":"2023","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.intimp.2026.116832_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-018-0251-z","article-title":"STING directly activates autophagy to tune the innate immune response","volume":"26","author":"Liu","year":"2019","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.intimp.2026.116832_bb0055","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797858","article-title":"Attenuation of c GAS - STING signaling is mediated by a p62\/SQSTM 1-dependent autophagy pathway activated by TBK1","volume":"37","author":"Prabakaran","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2026.116832_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00916-z","article-title":"CGAS-STING, an important pathway in cancer immunotherapy","author":"Jiang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.116832_bb0065","doi-asserted-by":"crossref","unstructured":"M. Shen et al., \u201cThe cGAS\u2013STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications,\u201d Dec. 01, 2025, BioMed Central Ltd. doi:https:\/\/doi.org\/10.1186\/s13045-025-01691-5, J. Hematol. Oncol.","DOI":"10.1186\/s13045-025-01691-5"},{"key":"10.1016\/j.intimp.2026.116832_bb0070","article-title":"\u201cDoxorubicin prodrug-based nanomedicines for the treatment of cancer,\u201d Oct. 05, 2023, Elsevier Masson s.r.l","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.116832_bb0075","article-title":"\u201c\u201cProgrammed Cell Death Protein 1\/Programmed Cell Death Protein Ligand 1 immunosuppressants in advanced Non-Small Cell Lung Cancer research progress in treatment,\u201d\u201d Jun. 16, 2022, Frontiers Media S.A","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116832_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.intimp.2026.116832_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-020-0668-4","article-title":"Characterizing the ecological and evolutionary dynamics of cancer","volume":"52","author":"Zahir","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2026.116832_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1255727","article-title":"Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment","author":"Attiq","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116832_bb0095","article-title":"\u201cThe promising role of tumor-associated macrophages in the treatment of cancer,\u201d Mar. 01, 2024, Churchill Livingstone","author":"Wang","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.intimp.2026.116832_bb0100","article-title":"Regulatory T cells in cancer immunotherapy","author":"Tanaka","year":"2017","journal-title":"Nat. Publ. Group"},{"key":"10.1016\/j.intimp.2026.116832_bb0105","article-title":"\u201cThe crossroad between tumor and endothelial cells,\u201d Dec. 01, 2024, Springer Science and Business Media Deutschland GmbH","author":"Ribatti","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2026.116832_bb0110","article-title":"\u201cTumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling,\u201d Dec. 01, 2022, BioMed Central Ltd","author":"Gao","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.intimp.2026.116832_bb0115","doi-asserted-by":"crossref","unstructured":"M. Xu, T. Zhang, R. Xia, Y. Wei, and X. Wei, \u201cTargeting the tumor stroma for cancer therapy,\u201d Dec. 01, 2022, BioMed Central Ltd. doi:https:\/\/doi.org\/10.1186\/s12943-022-01670-1, Mol. Cancer.","DOI":"10.1186\/s12943-022-01670-1"},{"key":"10.1016\/j.intimp.2026.116832_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1176807","article-title":"Tumor-associated macrophages: prognostic and therapeutic targets for cancer in humans and dogs","author":"Brady","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116832_bb0190","doi-asserted-by":"crossref","unstructured":"Q. H. Wu et al., \u201cRegulatory T cells as a therapeutic target in acute myocardial infarction\u201d Aug. 01, 2024, Elsevier Ltd. doi:https:\/\/doi.org\/10.1016\/j.molimm.2024.06.003, Mol. Immunol.","DOI":"10.1016\/j.molimm.2024.06.003"},{"key":"10.1016\/j.intimp.2026.116832_bb0120","doi-asserted-by":"crossref","unstructured":"H. Menon et al., \u201cRole of radiation therapy in modulation of the tumor stroma and microenvironment,\u201d 2019, Frontiers Media S.A. doi:https:\/\/doi.org\/10.3389\/fimmu.2019.00193, Front. Immunol.","DOI":"10.3389\/fimmu.2019.00193"},{"key":"10.1016\/j.intimp.2026.116832_bb0125","doi-asserted-by":"crossref","unstructured":"L. Zitvogel, L. Galluzzi, O. Kepp, M. J. Smyth, and G. Kroemer, \u201cType I interferons in anticancer immunity,\u201d Jul. 26, 2015, Nature Publishing Group. doi:https:\/\/doi.org\/10.1038\/nri3845, Nat. Rev. Immunol.","DOI":"10.1038\/nri3845"},{"key":"10.1016\/j.intimp.2026.116832_bb0130","series-title":"911 Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice","author":"Dong","year":"2022"},{"key":"10.1016\/j.intimp.2026.116832_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116832_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.116832_bb0145","doi-asserted-by":"crossref","unstructured":"X. Mao et al., \u201cCrosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives\u201d Dec. 01, 2021, BioMed Central Ltd. doi:https:\/\/doi.org\/10.1186\/s12943-021-01428-1, Mol. Cancer.","DOI":"10.1186\/s12943-021-01428-1"},{"issue":"12","key":"10.1016\/j.intimp.2026.116832_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.26153","article-title":"LncRNA-MALAT1 promotes angiogenesis of thyroid Cancer by modulating tumor-associated macrophage FGF2 protein secretion","volume":"118","author":"Huang","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.intimp.2026.116832_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/jso.21245","article-title":"IL-1\u03b1 secreted by colon cancer cells enhances angiogenesis: the relationship between IL-1a release and tumor cells' potential for liver metastasis","volume":"99","author":"Matsuo","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.intimp.2026.116832_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcb.2010.06.006","article-title":"Signaling by members of the TGF-\u03b2 family in vascular morphogenesis and disease","author":"Pardali","year":"2010","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.intimp.2026.116832_bb0165","series-title":"The Tumor Microenvironment","author":"Anderson","year":"2020"},{"key":"10.1016\/j.intimp.2026.116832_bb0170","article-title":"Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy","author":"Zheng","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.116832_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103155","article-title":"Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: biologic function, mechanisms and clinical prospection","author":"Hu","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2026.116832_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2022.101206","article-title":"RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing","author":"Webb","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.intimp.2026.116832_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109235","article-title":"Tumor-associated macrophages in lymphoma: from mechanisms to therapy","author":"Xiong","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116832_bb0200","doi-asserted-by":"crossref","unstructured":"F. Veglia, M. Perego, and D. Gabrilovich, \u201cMyeloid-derived suppressor cells coming of age review-article\u201d Feb. 01, 2018, Nature Publishing Group. doi:https:\/\/doi.org\/10.1038\/s41590-017-0022-x.","DOI":"10.1038\/s41590-017-0022-x"},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0205","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.immuni.2008.09.003","article-title":"The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation","volume":"29","author":"Zhong","year":"2008","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2013.07.023","article-title":"XStructure-function analysis of STING activation by c[G(2\u2032,5\u2032) pA(3\u2032,5\u2032)p] and targeting by antiviral DMXAA","volume":"154","author":"Gao","year":"2013","journal-title":"Cell"},{"issue":"7748","key":"10.1016\/j.intimp.2026.116832_bb0215","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-019-0998-5","article-title":"Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP\u2013AMP","volume":"567","author":"Shang","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.09.016","article-title":"Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response","volume":"49","author":"Marcus","year":"2018","journal-title":"Immunity"},{"issue":"45","key":"10.1016\/j.intimp.2026.116832_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaz2738","article-title":"NK cells mediate clearance of CD8+ T cell-resistant tumors in response to STING agonist","volume":"5","author":"Nicolai","year":"2020","journal-title":"Sci. Immunol."},{"issue":"549","key":"10.1016\/j.intimp.2026.116832_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9013","article-title":"cGAS-STING-mediated DNA sensing maintains CD8+ T cell stemness and promotes antitumor T cell therapy","volume":"12","author":"Li","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0235","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.celrep.2019.03.098","article-title":"Modular architecture of the STING C-terminal tail allows interferon and NF-\u03baB signaling adaptation","volume":"27","author":"de Oliveira Mann","year":"2019","journal-title":"Cell Rep."},{"issue":"14","key":"10.1016\/j.intimp.2026.116832_bb0240","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100225118","article-title":"TBK1 recruitment to STING activates both IRF3 and NF-\u03baB that mediate immune defense against tumors and viral infections","volume":"118","author":"Yum","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.056","article-title":"TBK1 and IKK\u03b5 act redundantly to mediate STING-induced NF-\u03baB responses in myeloid cells","volume":"31","author":"Balka","year":"2020","journal-title":"Cell Rep."},{"issue":"92","key":"10.1016\/j.intimp.2026.116832_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adj3945","article-title":"STING licensing of type I dendritic cells potentiates antitumor immunity","volume":"9","author":"Wang","year":"2024","journal-title":"Sci. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116832_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.11.047","article-title":"Magnitude of therapeutic STING activation determines CD8+ T cell-mediated anti-tumor immunity","volume":"25","author":"Sivick","year":"2018","journal-title":"Cell Rep."},{"issue":"79","key":"10.1016\/j.intimp.2026.116832_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn6612","article-title":"Selective STING stimulation in dendritic cells primes antitumor T cell responses","volume":"8","author":"Jneid","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2026.116832_bb0265","doi-asserted-by":"crossref","DOI":"10.1111\/febs.15640","article-title":"Molecular and spatial mechanisms governing STING signalling","author":"Balka","year":"2021","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.intimp.2026.116832_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112185","article-title":"NF-\u03baB activation enhances STING signaling by altering microtubule-mediated STING trafficking","volume":"42","author":"Zhang","year":"2023","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0275","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003459","article-title":"CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells","volume":"10","author":"Benoit-Lizon","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2026.116832_bb0280","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005151","article-title":"T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer","volume":"10","author":"Ni","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0285","article-title":"STING activated tumor-intrinsic type I interferon signaling promotes CXCR3 dependent antitumor immunity in pancreatic Cancer","volume":"12","author":"Vonderhaar","year":"2021","journal-title":"CMGH"},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49932-4","article-title":"Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses","volume":"15","author":"Malli Cetinbas","year":"2024","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.intimp.2026.116832_bb0295","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-023-01185-x","article-title":"STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2","volume":"25","author":"Zhang","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2026.116832_bb0300","article-title":"Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.116832_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2025.06.002","article-title":"Metabolic regulation of cGAS-STING signaling in the tumor microenvironment: dual immune roles and therapeutic implications","author":"Wu","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6769","key":"10.1016\/j.intimp.2026.116832_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl4089","article-title":"MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists","volume":"390","author":"Hsu","year":"2025","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33610-4","article-title":"Loss of Zfp335 triggers cGAS\/STING-dependent apoptosis of post-\u03b2 selection thymocytes","volume":"13","author":"Ratiu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116832_bb0330","doi-asserted-by":"crossref","unstructured":"Y. Wang, J. Luo, A. Alu, X. Han, Y. Wei, and X. Wei, \u201cCGAS-STING Pathway in cancer Biotherapy,\u201d 2020. doi:https:\/\/doi.org\/10.1186\/s12943-020-01247-w.","DOI":"10.1186\/s12943-020-01247-w"},{"issue":"8","key":"10.1016\/j.intimp.2026.116832_bb0335","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202008101","article-title":"Dot1l modulates the senescence-associated secretory phenotype through epigenetic regulation of il1a","volume":"220","author":"Leon","year":"2021","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.intimp.2026.116832_bb0340","doi-asserted-by":"crossref","unstructured":"J. P. Copp\u00e9, P. Y. Desprez, A. Krtolica, and J. Campisi, \u201cThe Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression,\u201d 2010. doi:https:\/\/doi.org\/10.1146\/annurev-pathol-121808-102144.","DOI":"10.1146\/annurev-pathol-121808-102144"},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0345","article-title":"Lysosome-mediated processing of chromatin in senescence","volume":"202","author":"Adams","year":"2013","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116832_bb0350","doi-asserted-by":"crossref","DOI":"10.1038\/ncb3586","article-title":"Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence","volume":"19","author":"Gl\u00fcck","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0355","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13329","article-title":"NAD+ supplementation prevents STING-induced senescence in ataxia telangiectasia by improving mitophagy","volume":"20","author":"Yang","year":"2021","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00573-w","article-title":"Signalling strength determines proapoptotic functions of STING","volume":"8","author":"Gulen","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0365","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.71.4.669","article-title":"IFN-\u03b12a induces IP-10\/CXCL10 and MIG\/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells","volume":"71","author":"Padovan","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2026.116832_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2018.11.003","article-title":"An analysis of the expression and association with immune cell infiltration of the cGAS\/STING pathway in Pan-Cancer","volume":"14","author":"An","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"2","key":"10.1016\/j.intimp.2026.116832_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2019.05.006","article-title":"SLC19A1 is an importer of the Immunotransmitter cGAMP","volume":"75","author":"Ritchie","year":"2019","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.intimp.2026.116832_bb0380","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1301205","article-title":"Rapid and unidirectional perforin pore delivery at the cytotoxic immune synapse","volume":"191","author":"Lopez","year":"2013","journal-title":"The Journal of Immunology"},{"issue":"7958","key":"10.1016\/j.intimp.2026.116832_bb0385","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41586-023-05880-5","article-title":"STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma","volume":"616","author":"Hu","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2026.116832_bb0390","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00262-017-1975-1","article-title":"Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site","volume":"66","author":"Ohkuri","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"12","key":"10.1016\/j.intimp.2026.116832_bb0395","doi-asserted-by":"crossref","DOI":"10.1172\/JCI95375","article-title":"HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells","volume":"127","author":"Veenhuis","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.intimp.2026.116832_bb0400","series-title":"Endothelial Type I Interferon Response and Brain Diseases: Identifying STING as a Therapeutic Target","author":"Duarte","year":"2023"},{"issue":"50","key":"10.1016\/j.intimp.2026.116832_bb0405","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1512832112","article-title":"STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity","volume":"112","author":"Demaria","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.intimp.2026.116832_bb0410","doi-asserted-by":"crossref","DOI":"10.1172\/JCI125413","article-title":"STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade","volume":"129","author":"Yang","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"7729","key":"10.1016\/j.intimp.2026.116832_bb0415","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-018-0629-6","article-title":"Nuclear cGAS suppresses DNA repair and promotes tumorigenesis","volume":"563","author":"Liu","year":"2018","journal-title":"Nature"},{"issue":"7689","key":"10.1016\/j.intimp.2026.116832_bb0420","doi-asserted-by":"crossref","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2026.116832_bb0425","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116832_bb0430","doi-asserted-by":"crossref","unstructured":"A. Attiq, L. J. Yao, S. Afzal, and M. A. Khan, \u201cThe Triumvirate of NF-\u03baB, Inflammation and Cytokine Storm in COVID-19,\u201d 2021. doi:https:\/\/doi.org\/10.1016\/j.intimp.2021.108255.","DOI":"10.1016\/j.intimp.2021.108255"},{"key":"10.1016\/j.intimp.2026.116832_bb0435","doi-asserted-by":"crossref","unstructured":"A. Decout, J. D. Katz, S. Venkatraman, and A. Ablasser, \u201cThe cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases,\u201d Sep. 01, 2021, Nature Research. doi:https:\/\/doi.org\/10.1038\/s41577-021-00524-z.","DOI":"10.1038\/s41577-021-00524-z"},{"issue":"5","key":"10.1016\/j.intimp.2026.116832_bb0440","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-20-0387","article-title":"Metastasis and immune evasion from extracellular cgamp hydrolysis","volume":"11","author":"Li","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.116832_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6166","article-title":"Inflammation-driven carcinogenesis is mediated through STING","volume":"5","author":"Ahn","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116832_bb0315","article-title":"STING in cancer immunoediting: modeling tumor-immune dynamics throughout cancer development","author":"Zhang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.116832_bb0320","doi-asserted-by":"crossref","unstructured":"\u201cthe cgas-sting pathway and cancer,\u201d pp. 1452\u20131463, Dec. 2022.","DOI":"10.1038\/s43018-022-00468-w"},{"issue":"8","key":"10.1016\/j.intimp.2026.116832_bb0450","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-15-1456","article-title":"STING promotes the growth of tumors characterized by Low antigenicity via IDO activation","volume":"76","author":"Lemos","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116832_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2025.12.007","article-title":"MITA\/STING-driven CD38 induction in Siglec-flow macrophages promotes regulatory T cell survival and non-small cell lung cancer progression","author":"Zhang","year":"2026","journal-title":"Dev. Cell"},{"issue":"7604","key":"10.1016\/j.intimp.2026.116832_bb0460","doi-asserted-by":"crossref","DOI":"10.1038\/nature18268","article-title":"Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer","volume":"533","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0465","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116832_bb0470","doi-asserted-by":"crossref","unstructured":"G. J. Weiner, \u201cCpG Oligodeoxynucleotide-Based Therapy of Lymphoid Malignancies,\u201d 2009. doi:https:\/\/doi.org\/10.1016\/j.addr.2008.12.006.","DOI":"10.1016\/j.addr.2008.12.006"},{"issue":"7368","key":"10.1016\/j.intimp.2026.116832_bb0475","doi-asserted-by":"crossref","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2026.116832_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001372","article-title":"Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles","volume":"8","author":"Cheng","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"7918","key":"10.1016\/j.intimp.2026.116832_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04847-2","article-title":"cGAS\u2013STING drives the IL-6-dependent survival of chromosomally instable cancers","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.intimp.2026.116832_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010725","article-title":"Human papillomaviruses sensitize cells to DNA damage induced apoptosis by targeting the innate immune sensor cGAS","volume":"18","author":"Gusho","year":"2022","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0495","article-title":"Increased Drp1 promotes autophagy and ESCC progression by mtDNA stress mediated cGAS-STING pathway","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116832_bb0500","doi-asserted-by":"crossref","unstructured":"P. K. Oduro et al., \u201cThe cGAS\u2013STING Signaling in Cardiovascular and Metabolic Diseases: Future Novel Target Option for Pharmacotherapy,\u201d 2022. doi:https:\/\/doi.org\/10.1016\/j.apsb.2021.05.011.","DOI":"10.1016\/j.apsb.2021.05.011"},{"key":"10.1016\/j.intimp.2026.116832_bb0505","doi-asserted-by":"crossref","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116832_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2021.12.162","article-title":"Radiation therapy promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation","volume":"112","author":"Du","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0515","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32335","article-title":"Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway","volume":"77","author":"Ma","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2026.116832_bb0520","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01198-9","article-title":"Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers","author":"Xu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0525","article-title":"STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2026.116832_bb0530","doi-asserted-by":"crossref","DOI":"10.7150\/thno.37745","article-title":"Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells","volume":"10","author":"Miao","year":"2020","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.intimp.2026.116832_bb0535","doi-asserted-by":"crossref","DOI":"10.1093\/immhor\/vlaf048","article-title":"Tumor cells upregulate CCL22 in a STING-dependent manner in response to paracrine factors released by STING-activated myeloid cells and type I interferons","volume":"9","author":"Lomashvili","year":"2025","journal-title":"Immunohorizons"},{"key":"10.1016\/j.intimp.2026.116832_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594775","article-title":"Tumor cell-secreted ISG15 promotes tumor cell migration and immune suppression by inducing the macrophage M2-like phenotype","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0545","doi-asserted-by":"crossref","first-page":"277","DOI":"10.7150\/thno.101001","article-title":"A STING agonist prodrug reprograms tumor-associated macrophage to boost colorectal cancer immunotherapy","volume":"15","author":"Deng","year":"2025","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.intimp.2026.116832_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107376","article-title":"STING-IRG1 inhibits liver metastasis of colorectal cancer by regulating the polarization of tumor-associated macrophages","volume":"26","author":"Liu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.intimp.2026.116832_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2024.07.039","article-title":"A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy","volume":"373","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.116832_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115618","article-title":"STING activation in macrophages by vanillic acid exhibits antineoplastic potential","volume":"213","author":"Zhu","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116832_bb0565","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006481","article-title":"Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL\/4-1BB co-stimulation","volume":"11","author":"Sun","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"15","key":"10.1016\/j.intimp.2026.116832_bb0570","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-22-3382","article-title":"PP2Ac deficiency enhances tumor immunogenicity by activating STING\u2013type I interferon signaling in glioblastoma","volume":"83","author":"Mondal","year":"2023","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.116832_bb0575","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162139","article-title":"PP2Ac\/STRN4 negatively regulates STING-type i IFN signaling in tumor-associated macrophages","volume":"133","author":"Ho","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.intimp.2026.116832_bb0580","doi-asserted-by":"crossref","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","author":"Ohkura","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2026.116832_bb0585","doi-asserted-by":"crossref","DOI":"10.1080\/14728222.2018.1451514","article-title":"FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity","author":"Whiteside","year":"2018","journal-title":"Expert Opin. Ther. Targets."},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0590","doi-asserted-by":"crossref","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2026.116832_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3 + regulatory T cell heterogeneity and function in autoimmunity and cancer","author":"Wing","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116832_bb0600","doi-asserted-by":"crossref","DOI":"10.1038\/nri2253","article-title":"The reverse stop-signal model for CTLA4 function","author":"Rudd","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"29","key":"10.1016\/j.intimp.2026.116832_bb0605","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2320709121","article-title":"STING trafficking activates MAPK\u2013CREB signaling to trigger regulatory T cell differentiation","volume":"121","author":"Lin","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.intimp.2026.116832_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.11.021","article-title":"Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for Treg suppressive function","volume":"31","author":"Field","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.06.009","article-title":"Interferon-independent activities of mammalian STING mediate antiviral response and tumor immune evasion","volume":"53","author":"Wu","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116832_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B Cells: origin, phenotype, and function","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116832_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.611795","article-title":"Immunosuppressive mechanisms of regulatory B Cells","author":"Catal\u00e1n","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116832_bb0630","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-19-0349","article-title":"Bcell-derived IL35 drives STAT3-dependent CD8+ T-cell exclusion in pancreatic cancer","volume":"8","author":"Mirlekar","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.116832_bb0635","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat. Immunol."},{"issue":"17","key":"10.1016\/j.intimp.2026.116832_bb0640","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9455","article-title":"STING couples with PI3K to regulate actin reorganization during BCR activation","volume":"6","author":"Jing","year":"2020","journal-title":"Sci. Adv."},{"issue":"7931","key":"10.1016\/j.intimp.2026.116832_bb0645","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-05254-3","article-title":"STING-induced regulatory B cells compromise NK function in cancer immunity","volume":"610","author":"Li","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116832_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116832_bb0655","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116832_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111627","article-title":"The function and therapeutic implications of TNF signaling in MDSCs","author":"Yu","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116832_bb0665","article-title":"Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor","author":"Li","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.116832_bb0670","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.116832_bb0675","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1050484","article-title":"The effects of dendritic cell-based vaccines in the tumor microenvironment: impact on myeloid-derived suppressor cells","author":"S\u00e1nchez-Le\u00f3n","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0680","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01566-5","article-title":"Host STING-dependent MDSC mobilization drives extrinsic radiation resistance","volume":"8","author":"Liang","year":"2017","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2026.116832_bb0685","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-019-0302-0","article-title":"STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.intimp.2026.116832_bb0690","article-title":"STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy","volume":"22","author":"Arwert","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116832_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.11.005","article-title":"Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0700","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03924-6","article-title":"Downregulation of cGAS\/STING expression in tumor cells by cancer-associated fibroblasts in colorectal cancer","volume":"15","author":"Kanoda","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116832_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(03)01018-0","article-title":"Antivascular therapy of cancer: DMXAA","author":"Baguley","year":"2003","journal-title":"Lancet. Oncol."},{"issue":"22","key":"10.1016\/j.intimp.2026.116832_bb0710","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1200\/JCO.2011.35.0660","article-title":"Randomized phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer","volume":"29","author":"Lara","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116832_bb0715","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1300097","article-title":"Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-Dimethylxanthenone-4-acetic acid","volume":"190","author":"Conlon","year":"2013","journal-title":"The Journal of Immunology"},{"issue":"5986","key":"10.1016\/j.intimp.2026.116832_bb0720","doi-asserted-by":"crossref","DOI":"10.1126\/science.1189801","article-title":"C-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response","volume":"328","author":"Woodward","year":"1979","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.intimp.2026.116832_bb0725","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.2c01305","article-title":"Design, synthesis, and biochemical and biological evaluation of novel 7-Deazapurine cyclic dinucleotide analogues as STING receptor agonists","volume":"65","author":"Vav\u0159ina","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.116832_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114796","article-title":"S-acylthioalkyl ester (SATE)-based prodrugs of deoxyribose cyclic dinucleotides (dCDNs) as the STING agonist for antitumor immunotherapy","volume":"243","author":"Xie","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.116832_bb0745","article-title":"Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.116832_bb0750","doi-asserted-by":"crossref","unstructured":"B. S. Pan et al., \u201cAn orally available non-nucleotide STING agonist with antitumor activity,\u201d Science (1979)., vol. 369, no. 6506, 2020, doi:https:\/\/doi.org\/10.1126\/science.aba6098.","DOI":"10.1126\/science.aba6098"},{"issue":"7","key":"10.1016\/j.intimp.2026.116832_bb0735","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"issue":"7736","key":"10.1016\/j.intimp.2026.116832_bb0740","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"issue":"7906","key":"10.1016\/j.intimp.2026.116832_bb0755","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04559-7","article-title":"Activation of STING by targeting a pocket in the transmembrane domain","volume":"604","author":"Lu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116832_bb0760","doi-asserted-by":"crossref","unstructured":"E. N. Chin et al., \u201cAntitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic,\u201d Science (1979)., vol. 369, no. 6506, 2020, doi:https:\/\/doi.org\/10.1126\/science.abb4255.","DOI":"10.1126\/science.abb4255"},{"issue":"10","key":"10.1016\/j.intimp.2026.116832_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.08.015","article-title":"MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer","volume":"40","author":"Kitajima","year":"2022","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.intimp.2026.116832_bb0770","doi-asserted-by":"crossref","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2026.116832_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2015.02.003","article-title":"The STING pathway and the T cell-inflamed tumor microenvironment","author":"Woo","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2026.116832_bb0780","doi-asserted-by":"crossref","unstructured":"X. Wu, N. Feng, C. Wang, H. Jiang, and Z. Guo, \u201cSmall molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance,\u201d 2024, Frontiers Media SA. doi:https:\/\/doi.org\/10.3389\/fimmu.2024.1444452, Front. Immunol.","DOI":"10.3389\/fimmu.2024.1444452"},{"key":"10.1016\/j.intimp.2026.116832_bb0785","doi-asserted-by":"crossref","unstructured":"P. J. Murray, \u201cMacrophage polarization,\u201d Feb. 10, 2017, Annual Reviews Inc. doi:https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034339, Annu. Rev. Physiol.","DOI":"10.1146\/annurev-physiol-022516-034339"},{"key":"10.1016\/j.intimp.2026.116832_bb0790","doi-asserted-by":"crossref","unstructured":"Y. Zong, K. Deng, and W. P. Chong, \u201cRegulation of Treg cells by cytokine signaling and co-stimulatory molecules,\u201d 2024, Frontiers Media SA. doi:https:\/\/doi.org\/10.3389\/fimmu.2024.1387975, Front. Immunol.","DOI":"10.3389\/fimmu.2024.1387975"},{"key":"10.1016\/j.intimp.2026.116832_bb0795","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116832_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2018.08.002","article-title":"Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells","volume":"122","author":"Palanisamy","year":"2019","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.intimp.2026.116832_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235819","article-title":"Targeting tumor endothelial cells with nanoparticles","author":"Sakurai","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116832_bb0810","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06119-x","article-title":"Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications","author":"Fang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116832_bb0815","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.26116","article-title":"Tangled fibroblasts in tumor-stroma interactions","author":"Liu","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2026.116832_bb0820","doi-asserted-by":"crossref","unstructured":"J. R. Libby, H. Royce, S. R. Walker, and L. Li, \u201cThe role of extracellular matrix in angiogenesis: beyond adhesion and structure,\u201d Sep. 01, 2024, Elsevier Ltd. doi:https:\/\/doi.org\/10.1016\/j.bbiosy.2024.100097, Biomaterials and Biosystems.","DOI":"10.1016\/j.bbiosy.2024.100097"},{"issue":"2","key":"10.1016\/j.intimp.2026.116832_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.05.035","article-title":"The cytoplasmic DNA sensor cGAS promotes mitotic cell death","volume":"178","author":"Zierhut","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0830","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41416-018-0188-5","article-title":"Sting agonist therapy in combination with pd-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer","volume":"119","author":"Ghaffari","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"13","key":"10.1016\/j.intimp.2026.116832_bb0835","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-018-0581-9","article-title":"Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles","volume":"38","author":"Grabosch","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2026.116832_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2016.04.058","article-title":"Interferon \u03b2 improves the efficacy of low dose cisplatin by inhibiting NF-\u03baB\/p-Akt signaling on HeLa cells","volume":"82","author":"Ethiraj","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.intimp.2026.116832_bb0845","article-title":"Interferon-\u03b2 produces synergistic combinatory anti-tumor effects with cisplatin or Pemetrexed on mesothelioma cells","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2014.08.010","article-title":"Synergistic anti-carcinogenic effect of interferon-\u03b2 with cisplatin on human breast adenocarcinoma MDA MB231 cells","volume":"23","author":"Ethiraj","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116832_bb0855","article-title":"Antitumor activity of cGAMP via stimulation of cGAS-cGAMP-STING-IRF3 mediated innate immune response","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.intimp.2026.116832_bb0860","doi-asserted-by":"crossref","DOI":"10.1093\/jjco\/hyr110","article-title":"The safety and tolerability of intravenous ASA404 when administered in combination with docetaxel (60 or 75 mg\/m2) in Japanese patients with advanced or recurrent solid tumors","volume":"41","author":"Daga","year":"2011","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116832_bb0865","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-09-3026","article-title":"Phase II study on the addition of ASA404 (vadimezan; 5,6- dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC","volume":"16","author":"Pili","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116832_bb0870","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00156","article-title":"Novel approaches to improve the efficacy of immuno-radiotherapy","author":"Shevtsov","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.116832_bb0875","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01207-z","article-title":"NF-\u03baB signaling in neoplastic transition from epithelial to mesenchymal phenotype","author":"Oh","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.intimp.2026.116832_bb0880","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2026.116832_bb0885","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116832_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116832_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116832_bb0900","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2015-000022","article-title":"Immune checkpoint blockade in small cell lung cancer: Is there a light at the end of the tunnel?","author":"Paglialunga","year":"2016","journal-title":"ESMO Open"},{"key":"10.1016\/j.intimp.2026.116832_bb0905","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-032414-112043","article-title":"Innate immune recognition of cancer","volume":"33","author":"Woo","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116832_bb0910","doi-asserted-by":"crossref","DOI":"10.1172\/JCI127471","article-title":"CGAS\/STING axis mediates a topoisomerase II inhibitor\u2013induced tumor immunogenicity","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.intimp.2026.116832_bb0915","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.intimp.2026.116832_bb0920","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"Parp inhibitor efficacy depends on CD8+ T-cell recruitment via intratumoral sting pathway activation in brca-deficient models of triple-negative breast cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.intimp.2026.116832_bb0925","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-18-1003","article-title":"PARPI triggers the STING-dependent immune response and enhances the therapeutic efficacy of immune checkpoint blockade independent of BRCANEss","volume":"79","author":"Shen","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116832_bb0930","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy424.015","article-title":"Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas","volume":"29","author":"Harrington","year":"2018","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116832_bb0935","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3590","article-title":"Clonal evolution of glioblastoma under therapy","volume":"48","author":"Wang","year":"2016","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.intimp.2026.116832_bb0940","doi-asserted-by":"crossref","DOI":"10.1038\/nm.3886","article-title":"Subclonal diversification of primary breast cancer revealed by multiregion sequencing","volume":"21","author":"Yates","year":"2015","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2026.116832_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.04.016","article-title":"An immune atlas of clear cell renal cell carcinoma","volume":"169","author":"Chevrier","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2026.116832_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast heterogeneity and immunosuppressive environment in human breast Cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb0965","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07767-w","article-title":"Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer","volume":"9","author":"Jia","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116832_bb0970","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-cancerbio-030617-050224","article-title":"Lineage plasticity in cancer progression and treatment","author":"Le Magnen","year":"2018","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.intimp.2026.116832_bb0975","doi-asserted-by":"crossref","DOI":"10.1038\/ncb3611","article-title":"Cell plasticity in epithelial homeostasis and tumorigenesis","author":"Varga","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116832_bb0980","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v11.i3.121","article-title":"Roles of cell fusion, hybridization and polyploid cell formation in cancer metastasis","volume":"11","author":"Shabo","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.116832_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2026.116832_bb0990","doi-asserted-by":"crossref","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","author":"Pollard","year":"2004","journal-title":"Nat. Rev. Cancer."},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb0995","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004992","article-title":"Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression","volume":"4","author":"Spaeth","year":"2009","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.intimp.2026.116832_bb1000","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-08-0943","article-title":"Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells","volume":"68","author":"Mishra","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116832_bb1005","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-016-0143-0","article-title":"Interaction of MSC with tumor cells","author":"Melzer","year":"2016","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.intimp.2026.116832_bb1010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082107","article-title":"Role of Msc in the tumor microenvironment","author":"Hass","year":"2020","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.intimp.2026.116832_bb1015","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-017-0120-0","article-title":"Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production","volume":"37","author":"Konno","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb1020","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37217-1","article-title":"Epigenetic state determines the in vivo efficacy of STING agonist therapy","volume":"14","author":"Falahat","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116832_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.04.009","article-title":"Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition","author":"Low","year":"2022","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.intimp.2026.116832_bb1030","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8 + T-CeII recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.116832_bb1035","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb1040","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1118599","article-title":"Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression","volume":"5","author":"Ma","year":"2016","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116832_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.01.044","article-title":"STING-associated lung disease in mice relies on T cells but not type I interferon","volume":"144","author":"Luksch","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2026.116832_bb1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108466","article-title":"Type I interferon-independent T cell impairment in a Tmem173 N153S\/WT mouse model of STING associated vasculopathy with onset in infancy (SAVI)","volume":"216","author":"Siedel","year":"2020","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116832_bb1055","article-title":"Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients","volume":"9","author":"Fr\u00e9mond","year":"2021","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"11","key":"10.1016\/j.intimp.2026.116832_bb1060","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1084\/jem.20171351","article-title":"STI NG-associated vasculopathy develops independently of IRF3 in mice","volume":"214","author":"Warner","year":"2017","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.intimp.2026.116832_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107771","article-title":"STING gain-of-function disrupts lymph node organogenesis and innate lymphoid cell development in mice","volume":"31","author":"Bennion","year":"2020","journal-title":"Cell Rep."},{"issue":"16","key":"10.1016\/j.intimp.2026.116832_bb1070","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1073\/pnas.1818281116","article-title":"Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models","volume":"116","author":"Motwani","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.intimp.2026.116832_bb1075","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20182192","article-title":"STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death","volume":"216","author":"Wu","year":"2019","journal-title":"Journal of Experimental Medicine"},{"issue":"9","key":"10.1016\/j.intimp.2026.116832_bb1080","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.2000028","article-title":"A defect in thymic tolerance causes T cell\u2013mediated autoimmunity in a murine model of COPA syndrome","volume":"204","author":"Deng","year":"2020","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116832_bb1085","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201045","article-title":"A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome","volume":"217","author":"Deng","year":"2020","journal-title":"Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/j.intimp.2026.116832_bb1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.05.008","article-title":"Dysbiosis exacerbates colitis by promoting ubiquitination and accumulation of the innate immune adaptor STING in myeloid cells","volume":"54","author":"Shmuel-Galia","year":"2021","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2026.116832_bb1095","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.intimp.2026.116832_bb1100","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.01.065","article-title":"STING signaling promotes inflammation in experimental acute pancreatitis","volume":"154","author":"Zhao","year":"2018","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.intimp.2026.116832_bb1105","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2018-317098","article-title":"STING signalling protects against chronic pancreatitis by modulating Th17 response","volume":"68","author":"Zhao","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2026.116832_bb1110","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201708092","article-title":"Senescence and aging: causes, consequences, and therapeutic avenues","author":"McHugh","year":"2018","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116832_bb1115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Copp\u00e9","year":"2008","journal-title":"PLoS Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926006788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926006788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:54:53Z","timestamp":1789242893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926006788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":223,"alternative-id":["S1567576926006788"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116832","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"cGAS-STING Signalling in the tumour microenvironment: Implications for immune surveillance and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116832","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116832"}}